News

Total contract value increases to $10 million from May 2022 TORONTO, ON – February 13, 2023 – Think Research Corporation (TSXV: THNK) (“Think” or the “Company”), a company

A Broad Range of Think Research Solutions Are Being Deployed to Help Solve Healthcare Access & Quality Challenges.

TORONTO, ON – December 30,  2022 – Think Research Corporation (TSXV: THNK) (“Think” or the “Company”), a company focused on transforming healthcare through digital health software solutions, today

TORONTO, ON – December 21, 2022 – Think Research Corporation (TSXV: THNK) (“Think” or the “Company”), a company focused on transforming healthcare through integrated digital

TORONTO, ON – December 19, 2022 – Think Research Corporation (TSXV: THNK) (“Think” or the “Company”), an innovative disruptor focused on transforming healthcare through digital health software solutions, is

Q3 revenue of $18.4 million grew 82% over the same period in 2021 99% revenue growth to $57.0 million in the first nine months of

Earnings to be announced by the Company before the market opens on November 28, 2022 TORONTO, ON – November 25, 2022  — Think Research Corporation (TSXV:THNK)(OTC: THKKF)

Additional $3 million to be received via second advance under $25 million convertible loan facility with Beedie Capital Infusion of $3 million of liquidity via

TORONTO, ON, October 14, 2022 – Think Research Corporation (TSXV:THNK) (“Think” or the “Company”), a healthcare technology company focused on transforming healthcare through knowledge-based digital health

TORONTO, ON – October 7, 2022 – Think Research Corporation (TSXV: THNK) (“Think” or the “Company”), a company focused on transforming healthcare through integrated digital health